Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Prostate Cancer Prevention

  • Vaqar M. Adhami
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_6812-2



Prostate cancer prevention refers to approaches and strategies that when taken result in decreased risk for the development and recurrence of cancer of the prostate gland.


The worldwide occurrence of prostate cancer shows strong variations. Western nations have the highest incidence and mortality rates, while Asian men tend to have the lowest rates of prostate cancer (prostate cancer epidemiology). These differences provide a strong rationale for implementation of strategies to prevent prostate cancer. In fact, prostate cancer is considered an ideal disease for prevention because it has a long latency period and is typically diagnosed in people over 50 years of age. Therefore, even a modest delay in neoplastic development achieved through pharmacological intervention could result in a substantial reduction in the incidence of clinically detectable disease. Avoiding risk factors and adopting protective factors may help...


Prostate Cancer Prostate Cancer Risk Pomegranate Juice Prostate Cancer Prevention Develop Prostate Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS, REDUCE Study Group (2010) Effect of dutasteride on the risk of prostate cancer. N Engl J Med 362:1192–1202CrossRefPubMedGoogle Scholar
  2. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66:1234–1240CrossRefPubMedGoogle Scholar
  3. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301:39–51CrossRefPubMedGoogle Scholar
  4. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A (2006) Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12:4018–4026CrossRefPubMedGoogle Scholar
  5. Syed DN, Khan N, Afaq F, Mukhtar H (2007) Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 16:2193–2203CrossRefPubMedGoogle Scholar
  6. Thompson IM, Tangen CM, Goodman PJ, Lucia MS, Klein EA (2009) Chemoprevention of prostate cancer. J Urol 182:499–507CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.School of Medicine and Public HealthUniversity of WisconsinMadisonUSA